DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
EMEPRONIUM
4
Small molecule
Approved
Unknown
Unknown
Polyuria; Urinary Incontinence
Unknown
EMEPRONIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
04QQ8SWA4U
Molecule Type:
Small molecule
Molecular Formula:
C20H28N+
Molecular Weight:
282.45
AlogP:
4.69
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
6.0
Source:
MIANSERIN HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MIANSERIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
2X03TN217S
Molecule Type:
Small molecule
Molecular Formula:
C18H21ClN2
Molecular Weight:
300.83
AlogP:
3.08
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
0.0
Source:
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
DOLUTEGRAVIR LAMIVUDINE TENOFOVIR ALAFENAMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OMBITASVIR; PARITAPREVIR; RITONAVIR
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
OMBITASVIR; PARITAPREVIR; RITONAVIR
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TBO-FILGRASTIM
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TBO-FILGRASTIM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FERROUS SULFATE; FOLIC ACID
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
FERROUS SULFATE; FOLIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
4
Combination
Approved
DIABETES DRUGS & ENDOCRINOLOGY; MUSCULOSKELETAL; OTHER; PREGNANCY AND GYNECOLOGY
ORAL-28
Unknown
Unknown
ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRITOQUALINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity
Unknown
TRITOQUALINE
×
Maximum Phase:
4
First Approval:
None
UNII:
F4MW5166YH
Molecule Type:
Small molecule
Molecular Formula:
C26H32N2O8
Molecular Weight:
500.55
AlogP:
3.64
PSA:
110.94
HBD:
1.0
HBA:
#RotB:
8.0
Source:
LEVOFLOXACIN; DEXTROSE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
LEVOFLOXACIN; DEXTROSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COLESEVELAM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
COLESEVELAM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
WAX, EMULSIFYING
4
Unknown
Approved
Unknown
Unknown
Cystitis, Interstitial; Leprosy; Multiple Sclerosis; Alzheimer Disease; Child Development Disorders, Pervasive; Severe Acute Respiratory Syndrome
Unknown
WAX, EMULSIFYING
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GALCANEZUMAB-GNLM
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
GALCANEZUMAB-GNLM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHENINDAMINE TARTRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PHENINDAMINE TARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
28725X3PV8
Molecule Type:
Small molecule
Molecular Formula:
C23H25NO6
Molecular Weight:
411.45
AlogP:
3.92
PSA:
3.24
HBD:
0.0
HBA:
#RotB:
1.0
Source:
DIHYDROTACHYSTEROL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Vitamin D receptor agonist
DIHYDROTACHYSTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
R5LM3H112R
Molecule Type:
Small molecule
Molecular Formula:
C28H46O
Molecular Weight:
398.68
AlogP:
7.72
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
5.0
Source:
DOLUTEGRAVIR SODIUM; LAMIVUDINE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
DOLUTEGRAVIR SODIUM; LAMIVUDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IBUFENAC
4
Small molecule
Approved
Unknown
Unknown
Unknown
Cyclooxygenase inhibitor
IBUFENAC
×
Maximum Phase:
4
First Approval:
None
UNII:
5V4WIX44VI
Molecule Type:
Small molecule
Molecular Formula:
C12H16O2
Molecular Weight:
192.26
AlogP:
2.51
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALISKIREN HEMIFUMARATE; VALSARTAN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ALISKIREN HEMIFUMARATE; VALSARTAN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIAMMONIUM GLYCYRRHIZINATE
4
Unknown
Approved
Unknown
Unknown
Hepatitis B, Chronic
Unknown
DIAMMONIUM GLYCYRRHIZINATE
×
Maximum Phase:
4
First Approval:
None
UNII:
A9ZZD585U6
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDACATEROL FUMARATE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
INDACATEROL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL
4
Combination
Approved
Unknown
INTRAVENOUS
Unknown
Unknown
FISH OIL; MEDIUM CHAIN TRIGLYCERIDES; OLIVE OIL; SOYBEAN OIL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHOLINE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CHOLINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XAMOTEROL
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Beta-1 adrenergic receptor partial agonist
XAMOTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
7HE0JQL703
Molecule Type:
Small molecule
Molecular Formula:
C16H25N3O5
Molecular Weight:
339.39
AlogP:
-0.24
PSA:
103.29
HBD:
4.0
HBA:
#RotB:
8.0
Source:
REPROTEROL
4
Small molecule
Approved
Unknown
Unknown
Asthma; Lung Diseases, Obstructive
Unknown
REPROTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
11941YC6RN
Molecule Type:
Small molecule
Molecular Formula:
C18H23N5O5
Molecular Weight:
389.41
AlogP:
-0.44
PSA:
134.54
HBD:
4.0
HBA:
#RotB:
7.0
Source:
AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KRYPTON
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
KRYPTON
×
Maximum Phase:
4
First Approval:
None
UNII:
5I8I620HVX
Molecule Type:
Small molecule
Molecular Formula:
Kr
Molecular Weight:
83.8
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MOXONIDINE
4
Small molecule
Approved
Unknown
Unknown
Hypotension, Orthostatic; Heart Diseases; Hypertension
Nischarin agonist
MOXONIDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
CC6X0L40GW
Molecule Type:
Small molecule
Molecular Formula:
C9H12ClN5O
Molecular Weight:
241.68
AlogP:
0.82
PSA:
71.43
HBD:
2.0
HBA:
#RotB:
2.0
Source:
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE
4
Combination
Approved
CARDIOVASCULAR
ORAL
Unknown
Unknown
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PHYSOSTIGMINE SULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PHYSOSTIGMINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
G63V2J2N71
Molecule Type:
Small molecule
Molecular Formula:
C30H44N6O8S
Molecular Weight:
648.78
AlogP:
1.77
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
1.0
Source:
HETASTARCH
4
Oligosaccharide
Approved
Unknown
Unknown
Peripheral Vascular Diseases; Hemorrhage
Unknown
HETASTARCH
×
Maximum Phase:
4
First Approval:
None
UNII:
875Y4127EA
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECHNETIUM TC-99M FERPENTETATE KIT
4
Unknown
Approved
OTHER
INJECTION
Unknown
Unknown
TECHNETIUM TC-99M FERPENTETATE KIT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LACTOBACILLUS ACIDOPHILUS
4
Unknown
Approved
Unknown
Unknown
Deglutition Disorders; Asthma; Fatty Liver; Klebsiella Infections; Non-alcoholic Fatty Liver Disease; Adenomatous Polyposis Coli; Constipation; Diarrhea; Hirschsprung Disease; Mastitis; Osteoporosis; Brain Diseases; Crohn Disease; Irritable Bowel Syndrome; Rectal Neoplasms; Rhinitis, Allergic, Seasonal; Stomatitis
Probiotic
LACTOBACILLUS ACIDOPHILUS
×
Maximum Phase:
4
First Approval:
None
UNII:
1PRR1V42V5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAMIPIDE
4
Small molecule
Approved
Unknown
Unknown
Colitis, Ulcerative; Head and Neck Neoplasms; Arthritis, Rheumatoid; Dry Eye Syndromes; Gastritis; Gastroesophageal Reflux; Osteoarthritis; Peptic Ulcer; Spondylitis, Ankylosing; Stomach Ulcer
Unknown
REBAMIPIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
LR583V32ZR
Molecule Type:
Small molecule
Molecular Formula:
C19H15ClN2O4
Molecular Weight:
370.79
AlogP:
2.61
PSA:
99.26
HBD:
3.0
HBA:
#RotB:
5.0
Source:
PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE
4
Combination
Approved
OTHER
TOPICAL
Unknown
Unknown
PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
254
255
256
257
258
259
260
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA